Immunology for Engineers

Inbunden, Engelska, 2024

Del 140 i serien Advances in Protein Chemistry and Structural Biology

1 878 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Immunology for Engineers, Volume 140 consists of chapters from stalwarts of the field, covering topics such as antibody engineering, adjuvant requirement and its methodology for assessment, and the need to develop immunotherapy, etc. Chapters covered in this volume discuss Current Status and Future Prospective of Breast Cancer Immunotherapy, Engineering high affinity antigen binders- beyond antibodies, Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells, Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life, and Molecular insights and promise of Oncolytic Virus based Immunotherapy.

Presents the latest in immunological engineering
Delves into timely topics such as antibody engineering
Covers vaccine engineering amongst many other important topics

Produktinformation

Utgivningsdatum:2024-05-16
Mått:152 x 229 x 34 mm
Vikt:1 060 g
Format:Inbunden
Språk:Engelska
Serie:Advances in Protein Chemistry and Structural Biology
Antal sidor:578
Förlag:Elsevier Science
ISBN:9780443193507

Utforska kategorier

Mer om författaren

Dr. Vijay Kumar Prajapati is an Associate Professor in the Department of Biochemistry at the University of Delhi South Campus, New Delhi, India. He specializes in cell-death research, parasitology, and therapeutic developments for infectious diseases. He has published extensively in international journals and contributed chapters to reputable publishers. He is a recipient of the INSA Medal for Young Scientist from the Indian National Science Academy and an Associate of the Indian Academy of Sciences, Bengaluru. His work has appeared in leading journals spanning infectious diseases and cellular physiology, reflecting a high scholarly impact and a broad research portfolio.

Innehållsförteckning

1. PrefaceVijay Kumar Prapajati2. Current Status and Future Prospective of Breast Cancer ImmunotherapyAnurag S. Rathore3. Engineering high affinity antigen binders- beyond antibodiesRajeev Kumar Pandey4. Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune CellsSunil Kumar SINGH5. Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free lifeBajarang Vasant Kumbhar6. Molecular insights and promise of Oncolytic Virus based ImmunotherapyBalachandar Vellingiri